Genetic polymorphisms of lysophosphatidic acid receptor 1 are associated with the onset of taxane-induced peripheral neuropathy

Br J Anaesth. 2021 Aug;127(2):e43-e46. doi: 10.1016/j.bja.2021.04.014. Epub 2021 May 21.
No abstract available

Keywords: chemotherapy-induced peripheral neuropathy; genetic polymorphism; lysophosphatidic acid receptor; neuropathic pain; single-nucleotide polymorphism.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Bridged-Ring Compounds / adverse effects*
  • Female
  • Humans
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / genetics*
  • Polymorphism, Genetic / genetics*
  • Receptors, Lysophosphatidic Acid / genetics*
  • Taxoids / adverse effects*

Substances

  • Antineoplastic Agents
  • Bridged-Ring Compounds
  • Receptors, Lysophosphatidic Acid
  • Taxoids
  • taxane